Wegovy Cut Albuminuria by Half in Non-Diabetic CKD

MedPage Today) — SAN DIEGO — Semaglutide (Wegovy) reduced albuminuria in patients with overweight or obesity and chronic kidney disease (CKD) but without type 2 diabetes, a randomized trial showed.
Among 101 patients, those who received 2…